Practical Application of Toxicology in Drug Development Course
Date: September 5th – 14th 2022
Location: This course will take place online. Pre-recorded lectures will be available prior to the live sessions.
This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the world. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with an emphasis on the practical application of these principles and the interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective.
The course is intended to benefit those from both biotechnology and pharmaceutical companies as well as CROs working with either small or large molecules, along with those from regulatory agencies and academia who are interested in toxicology and its application in the safety assessment of drugs and medical products. Early career scientists seeking a more in-depth knowledge and understanding of the role of toxicology in safety assessment will also benefit. The course is suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) looking to make a career change to work in drug safety assessment.
The course is recognised by EUROTOX as providing 37 hours of CPD and approved by the Royal Society of Biology for 96 CPD credits.
On-demand access to the presentations will be available to registrants for unlimited viewing no later than August 20th 2022 until October 1st 2022.
Virtual Features
• Virtual interactive case studies and break out groups
• Live Q&A Sessions with Speakers
• Recorded lectures and associated course materials with unlimited on-demand viewing
The course will take place from September 5th to 14th 2022 and will be held virtually. Pre-recorded lectures will be made available to registrants for unlimited viewing no later than August 20th 2022. Live Q&A sessions will be held with the speakers on September 5th, 7th, 9th, 12th &14th 2022. This annual course is a collaboration between the American College of Toxicology (ACT), the British Toxicology Society (BTS) and the Cambridge Alliance on Medicines Safety (CAMS).
Registration is now open for the course until September 4th 2022.
To register your place please follow the link here to a secure payment page.
Registration rates:
2022 Registration fees
ACT/BTS Member £950.00
Student £950.00
Non-Member £1,250.00
Government £950.00
Group (3 or more from same company)
ACT/BTS Member Group Rate* £850.00
Non-Member Group Rate* £1,150.00
*If you wish to avail of the group rate please contact the organisers at the Cambridge Alliance on Medicines Safety (cats@admin.cam.ac.uk) who will be able to process your request.
Note: Payments will be processed in GBP £
Refund Policy: We will not be able to offer refunds for virtual courses. Health-related refunds will be considered on a case-by-case basis. These special cancellation requests should be submitted in writing to cats@admin.cam.ac.uk. A £75 processing fee will be charged for cancellations.
The course organisers recognise the challenges faced by researchers in low-and-middle income countries (LMIC), including reduced access to training opportunities and have made available a limited number of bursaries to cover the cost of registration for those who may not otherwise be able to join. Applicants should be from an LMIC country and working at a LMIC based research or government organisation.
If you would like to be considered for a PATDD bursary please send the following to patdd@admin.cam.ac.uk by 12:00 BST on August 25th 2022:
1)- A letter of application stating why you would like to attend this course and what the benefit would be to your career and your organisation.
2)- A letter of support from your employer outlining your suitability for joining this course and the benefits it would bring. (Please note, letters of support should be submitted from an organisational email address)
Course Material
Access to the PATDD course material will be provided approximately two weeks before the start of the course. Access to this material will be restricted to those who have registered in full.
Course overview (Times and speakers to be confirmed)
Monday September 5th 2022 12.00-14.00 BST
Overview of Drug Discovery and Development; Ruth Roberts, Apconix
Pharmacology - Rob Wallis, Safety Pharmacology Consultant
Safety Pharmacology - Rob Wallis, Safety Pharmacology Consultant
DMPK and ADME, Concepts and Technologies - Kunal Taskar, GSK
Wednesday September 7th 2022 12.00-14.00 BST
Pathology - Vasanthi Mowat, Labcorp
Clinical Pathology - Jo Harding and Peter Cotton, Astra Zeneca
Organ Systems; Part I - John Foster, Senior Pathology Consultant
Organ Systems; Part II - Matt Jacobsen, AstraZeneca
Friday September 9th 2022 14.30-16.30 BST
Genetic Toxicology - George Johnson, Swansea University
Carcinogenicity - Nigel Roome, Toxicology and Toxicologic Pathology Consultant
Reproductive/Developmental Toxicology – Gary Chellman, Charles River Laboratories
Safety of Biotechnology Products - Lolke de Haan, ADC Therapeutics
Monday September 12th 2022 12.00-14.00 BST
Regulatory Safety Studies for Cell and Gene Therapy Products - Jan Klapwijk, Cornelis Consulting
Immunotoxicology - Marc Pallardy, Université Paris-Saclay
Risk Assessment - Ernie Harpur, Newcastle University
Regulatory Toxicology - David Jones, Regulatory consultant
Wednesday September 14th 2022 14.00-17.00 BST
Regulatory Case Studies – Full details TBC
